Gabriel Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, Inc., filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 200,000 shares of Hinge Health common stock on NYSE.
Key Highlights
- Proposed sale: 200,000 shares of Hinge Health common stock with an aggregate market value of $24,646,000.00, according to the filing.
- Approximate sale date: November 11, 2026, executed through Morgan Stanley Smith Barney LLC Executive Financial Services.
- Source of shares: 200,000 shares acquired on 05/21/2025 via Restricted Stock Units from the issuer, with payment date of 05/21/2025.
- 10b5-1 plan: The filing states a Rule 10b5-1 trading plan was adopted on 06/12/2026.
- Shares outstanding: 68,485,043 shares of common stock outstanding, as reported in the filing.
- Prior sales in past 3 months: Mecklenburg sold 200,000 shares on 10/12/2026 for gross proceeds of $20,626,366.67; 150,000 shares on 09/14/2026 for $13,982,805.00; and 250,000 shares on 09/11/2026 for $22,242,075.00, all under a 10b5-1 plan.
Mecklenburg's Proposed November 2026 Common Stock Sale at Hinge Health
According to the Form 144 filing, Gabriel Mecklenburg, who serves as both a Director and Executive Chairman and Co-Founder of Hinge Health, Inc. (NYSE:HNGE), proposed to sell 200,000 shares of the company's common stock. The filing lists an aggregate market value of $24,646,000.00 for the proposed sale, with an approximate sale date of November 11, 2026. The broker named in the filing is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
The filing discloses that the 200,000 shares to be sold were acquired on 05/21/2025 through a Restricted Stock Unit grant from the issuer, with a payment date of 05/21/2025. Mecklenburg indicated reliance on a Rule 10b5-1 trading plan, stating that the plan was adopted on 06/12/2026. The filing's remarks section notes that "Sales that were executed on November 11, 2026 are being reported on this Form 144 filed on November 12, 2026 given the EDGAR system was not accepting filings on November 11, 2026 in observance of the federal holiday."
The filing also reports three prior sales by Mecklenburg under a 10b5-1 plan within the past three months: 200,000 shares sold on 10/12/2026 for gross proceeds of $20,626,366.67; 150,000 shares sold on 09/14/2026 for gross proceeds of $13,982,805.00; and 250,000 shares sold on 09/11/2026 for gross proceeds of $22,242,075.00. All three prior transactions are attributed to Mecklenburg at 455 Market Street, Suite 700, San Francisco, CA 94105.
What Was Disclosed
Hinge Health's Executive Chairman and Co-Founder Gabriel Mecklenburg filed a Form 144 disclosing a proposed sale of 200,000 common shares with an aggregate market value of $24,646,000.00, executed under a 10b5-1 plan adopted on 06/12/2026, with the filing submitted on November 12, 2026.




Please wait processing your request...